Horus Pharma Acquires Significant Stake in Inocare Pharm
November 5, 2024
Horus Pharma has purchased a significant participation in Inocare Pharm, a Bucharest-based company that commercializes ophthalmic medical devices, diagnostic instruments and dietary supplements. The investment — Horus Pharma's first outside France — is intended to expand Horus's presence into Romania, the Balkans and CIS markets while strengthening Inocare Pharm's product portfolio and market position.
- Buyers
- Horus Pharma
- Targets
- Inocare Pharm
- Industry
- Medical Devices
- Location
- Romania
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Rhône Acquires Invacare Europe and Direct Healthcare Group to Create DHCare
January 30, 2026
Medical Devices
Rhône has completed acquisitions of Invacare Holdings S.ar.l. (Invacare Europe & APAC) and Direct Healthcare Group (DHG) through vehicles held by its Fund VI and combined the businesses to form DHCare, a London‑headquartered medical device platform. The transaction closed January 30, 2026; ARCHIMED will retain a minority stake in the newly formed company, which expands the combined product portfolio across mobility, seating, pressure‑care, patient handling and rental/services.
-
Pharmaron Acquires 82.54% of Biortus Biosciences
October 28, 2025
Healthcare Services
Pharmaron Beijing Co., Limited has entered into a definitive Share Purchase Agreement to acquire 82.54% of Biortus Biosciences Co., Ltd. and its affiliates. The transaction is expected to close after satisfaction of customary closing conditions and is intended to strengthen Pharmaron’s structure-based drug discovery and protein science capabilities.
-
Veranex Acquires HORUS Scientific
May 1, 2024
Healthcare Services
Veranex has acquired HORUS Scientific, a pathology and histology provider, to deepen its preclinical pathology and histology capabilities and expand its North American service footprint. The acquisition adds specialized GLP-capable histopathology services to Veranex’s integrated medtech service platform and complements its existing Paris pathology capabilities.
-
Sunshine Biopharma Inc. Acquires Nora Pharma Inc.
October 20, 2022
Pharmaceuticals
Sunshine Biopharma Inc. has completed the acquisition of all outstanding shares of Nora Pharma Inc., making Nora Pharma a wholly owned subsidiary. The deal (C$30.0 million) expands Sunshine’s business into generic prescription drugs, over‑the‑counter products and biosimilars and adds approximately $10.7 million in revenue and 36 employees based in the Greater Montreal area.
-
The Vistria Group Acquires BioCare, Inc.
November 8, 2021
Healthcare Services
The Vistria Group has acquired BioCare, Inc., a Tempe-based specialty pharmaceutical distributor, specialty pharmacy and pharmaceutical logistics provider. The deal is Vistria’s first investment from its $2.68 billion Fund IV and aims to support BioCare’s growth — both organically and via acquisitions — to expand access to therapies for rare and orphan diseases.
-
Equistone Partners Europe Acquires Majority Stake in Omnicare
August 14, 2019
Pharmaceuticals
Equistone Partners Europe has agreed to acquire a majority stake in Omnicare, a German pharmaceutical wholesaler specializing in distribution of finished medicines to compounding pharmacies for patient-specific oncology treatments. The seller is a consortium of shareholders that will retain a stake; Omnicare’s management, led by Oliver Tamimi, will remain in place and the deal (terms undisclosed) is expected to close in Q4 2019.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.